Nanofiller Fibre-Reinforced Polymer Nanocomposites

In this work, the technology of nano and micro-scale particle reinforcement concerning various polymeric fibre-reinforced systems including polyamides (PA), polyesters, polyurethanes, polypropylenes and high performance/temperature engineering polymers such as polyimide (PI), poly(ether ether ketone) (PEEK), polyarylacetylene (PAA) and poly p-phenylene benzobisoxazole (PBO) is reviewed. When the diameters of polymer fibre materials are shrunk from micrometers to submicrons or nanometers, there appear several unique characteristics such as very large surface area to volume ratio (this ratio for a nanofibre can be as large as 103 times of that of a microfibre), flexibility in surface functionalities and superior mechanical performance (such as stiffness and tensile strength) compared with any other known form of the material. However, nanoparticle reinforcement of fibre reinforced composites has been shown to be a possibility, but much work remains to be performed in order to understand how nanoreinforcement results in dramatic changes in material properties. The understanding of these phenomena will facilitate their extension to the reinforcement of more complicated anisotropic structures and advanced polymeric composite systems

Polymer/montmorillonite nanocomposites with improved thermal properties: Part II. Thermal stability of montmorillonite nanocomposites based on different polymeric matrixes.

In previous part of this work factors influencing the thermal stability of polymer nanocomposite materials were indicated, such as chemical constitution of organic modifier, filler content, nanocomposites’ structure and the processing- dependent degree of homogenization of nanofiller, were presented. In this part the basic changes in thermal behaviour of different polymeric matrixes (e.g. polyolefins, polyamides, poly(vinyl chloride) and styrene-containing polymers) upon addition of montmorillonite have been described. Brief description of the kinetics of the decomposition process in inert and oxidative environment, as well as analysis of volatile and condensed products of degradation, have also been present

Influence of surfactant on dynamics of photoinduced motions and light emission of a dye-doped deoxyribonucleic

Pure deoxyribonucleic acid (DNA) is known to be soluble in water only and exhibits poor temperature stability. In contrary, it is well known that the complex of DNA - with cetyltrimethyl ammonium (CTMA) is insoluble in water but soluble in alcohols and can be processed into very good optical quality thin films by solution casting or spin deposition. Despite the success of DNA-CTMA, there is still need for new cationic surfactants which would extend the range of available solvents for DNA complex. We test and present experimental results of influence of new surfactants replacing CTMA in the DNA complex and based on benzalkonium chloride (BA) and didecyldimethylammonium chloride (DDCA) on their optical properties. Particularly, we were interested in all optical switching and light generation in amplified spontaneous emission process in these materials

Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration

Nowadays, regenerative medicine faces a major challenge in providing new, functional materials that will meet the characteristics desired to replenish and grow new tissue. Therefore, this study presents new ceramic-polymer composites in which the matrix consists of tricalcium phosphates covered with blends containing a chemically bounded diclofenac with the biocompatible polymer-poly(3-hydroxyoctanoate), P(3HO). Modification of P(3HO) oligomers was confirmed by NMR, IR and XPS. Moreover, obtained oligomers and their blends were subjected to an in-depth characterisation using GPC, TGA, DSC and AFM. Furthermore, we demonstrate that the hydrophobicity and surface free energy values of blends decreased with the amount of diclofenac modified oligomers. Subsequently, the designed composites were used as a substrate for growth of the pre-osteoblast cell line (MC3T3-E1). An in vitro biocompatibility study showed that the composite with the lowest concentration of the proposed drug is within the range assumed to be non-toxic (viability above 70%). Cell proliferation was visualised using the SEM method, whereas the observation of cell penetration into the scaffold was carried out by confocal microscopy. Thus, it can be an ideal new functional bone tissue substitute, allowing not only the regeneration and restoration of the defect but also inhibiting the development of chronic inflammation

Physicochemical and biological characterisation of diclofenac oligomeric poly(3-hydroxyoctanoate) hybrids as β-TCP ceramics modifiers for bone tissue regeneration

Nowadays, regenerative medicine faces a major challenge in providing new, functional materials that will meet the characteristics desired to replenish and grow new tissue. Therefore, this study presents new ceramic-polymer composites in which the matrix consists of tricalcium phosphates covered with blends containing a chemically bounded diclofenac with the biocompatible polymer—poly(3-hydroxyoctanoate), P(3HO). Modification of P(3HO) oligomers was confirmed by NMR, IR and XPS. Moreover, obtained oligomers and their blends were subjected to an in-depth characterisation using GPC, TGA, DSC and AFM. Furthermore, we demonstrate that the hydrophobicity and surface free energy values of blends decreased with the amount of diclofenac modified oligomers. Subsequently, the designed composites were used as a substrate for growth of the pre-osteoblast cell line (MC3T3-E1). An in vitro biocompatibility study showed that the composite with the lowest concentration of the proposed drug is within the range assumed to be non-toxic (viability above 70%). Cell proliferation was visualised using the SEM method, whereas the observation of cell penetration into the scaffold was carried out by confocal microscopy. Thus, it can be an ideal new functional bone tissue substitute, allowing not only the regeneration and restoration of the defect but also inhibiting the development of chronic inflammation

Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets

Hydrophilic matrix systems are currently some of the most widely used drug delivery systems for controlled-release oral dosage forms. Amongst a variety of polymers, polyethylene oxide (PEO) is considered an important material used in pharmaceutical formulations. As PEO is sensitive to thermal oxidation, it is susceptible to free radical oxidative attack. The aim of this study was to investigate the stability of PEO based formulations containing different model drugs with different water solubility, namely propranolol HCl, theophylline and zonisamide. Both polyox matrices 750 and 303 grade were used as model carriers for the manufacture of tablets stored at 40 °C. The results of the present study suggest that the drug release from the matrix was affected by the length of storage conditions, solubility of drugs and the molecular weight of the polymers. Generally, increased drug release rates were prevalent in soluble drug formulations (propranolol) when stored at the elevated temperature (40 °C). In contrast, it was not observed with semi soluble (theophylline) and poorly soluble (zonisamide) drugs especially when formulated with PEO 303 polymer. This indicates that the main parameters controlling the drug release from fresh polyox matrices are the solubility of the drug in the dissolution medium and the molecular weight of the polymer. DSC traces indicated that that there was a big difference in the enthalpy and melting points of fresh and aged PEO samples containing propranolol, whereas the melting point of the aged polyox samples containing theophylline and zonisamide was unaffected